Dr. Kimberly Blackwell, a clinical
oncologist, at the Duke Cancer Institute
is included in this year's roster of Time
magazine's 100 Most Influential People.
Blackwell is professor of medicine and
director of the breast cancer
program at Duke Cancer Institute.
Dr. Blackwell has been involved in some
of the most important research in breast
cancer treatments in recent years.
She was the principal investigator on a
pivotal drug study announced last summer.
The US Food and Drug Administration
approved a new class of treatment for
advanced HER2 positive breast
cancer earlier this year.
Blackwell is also a clinician who
provides clinical care in a busy
practice at the Duke Cancer Center
focusing on complex breast cancer cases
Including among women under age 40.
Blackwell joined Duke
in 1994 as an intern.
The Time Magazine's list of 100 most
influential people recognizes activism,
innovation, and achievement.
